𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines

✍ Scribed by Yoram Wollman; Iris Shahar; Milton Goldstein; Judith Leibovici


Publisher
Springer US
Year
1994
Tongue
English
Weight
678 KB
Volume
19
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of hypoxia on drug resistance ph
✍ Bertrand C. Liang πŸ“‚ Article πŸ“… 1996 πŸ› Springer US 🌐 English βš– 516 KB

Recurrent gliomas are most often treated by chemotherapy. However, these tumors typically acquire resistance to most drugs administered, and patients will usually die of recurrent tumor. Factors which may play a role include overexpression of putative multidrug resistance genes, such as the multidru

Truncated midkine correlates with sensit
✍ Natsuyo Akuzawa; Shigenori Nobata; Takao Shinozawa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 213 KB

## Abstract Midkine (MK) is a heparin binding growth factor having functions of neurite‐outgrowth, mitogenesis and tissue repair. This molecule is involved in tumor growth and metastasis. The MK molecule consists of five exons, but there is a truncated isoform, lacking exon 3. We established SW13 c

Increased LRP mRNA expression is associa
✍ Carolyn M. LaurenΓ§ot; George L. Scheffer; Rik J. Scheper; Robert H. Shoemaker πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 175 KB πŸ‘ 2 views

Multidrug resistance (MDR) in human cancer cells is multifactorial. Previously, we reported on the association between expression of P-glycoprotein (Pgp), the multidrug resistanceassociated protein (MRP), and the lung resistance protein (LRP) with the MDR phenotype in the NCI panel of 60 human cance

In vitro response of human small-cell lu
✍ E. F. Smit; E. G. E. de Vries; H. Timmer-Bosscha; L. F. H. M. de Leij; J. W. Oos πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 844 KB

Three cell lines derived from small-cell lung carcinoma (SCLC) tumors of patients who had no clinical response after treatment with a multi-drug regimen were compared to 3 cell lines derived from tumors of patients who, upon treatment, showed a complete clinical response. These 2 groups of cell line